Progression in the mechanism of action and drug resistance of anaplastic lymphoma kinase inhibitors

doi:10.3969/j.issn.1672-3384.2019.09.003

PDF(1114 KB)

Clinical Medication Journal ›› 2019, Vol. 17 ›› Issue (9) : 10-14. DOI: 10.3969/j.issn.1672-3384.2019.09.003

Review

Progression in the mechanism of action and drug resistance of anaplastic lymphoma kinase inhibitors

{{article.zuoZhe_EN}}

Author information +

History +

HeighLight

Abstract

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2019, 17(9): 10-14 https://doi.org/10.3969/j.issn.1672-3384.2019.09.003

References

List( Publishing order | Descend order by publishing year | Descend order by cited within ) Chart analysis

References

Funding

RIGHTS & PERMISSIONS

PDF(1114 KB)

Accesses

Citation

Detail

Sections

Recommended

Received	Published
2019-05-18	2019-09-28
Issue Date
2019-09-28

Please choose a citation manager

Content to export